CD14 and COVID-19: This hypothesis is supported by Teixeira et al., who reported increased levels of bacterial translocation markers like LPS and CD14 in patients with COVID-19 pneumonia compared to patients with bacterial pneumonia, as well as amongst COVID-19 non-survivors and survivors18.